ASPIRE: A Registry Study Of Chinese Patients With TCE-RRMM Treated By Elranatamab
Clinical trial NCT07320326 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07320326
- Sponsor
- Peking University People's Hospital
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-12-30
- Primary completion
- 2028-07-18
- Enrollment
- 159
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.